Last fall, I wrote in Forbes about U.S. based biotechnology manufacturer Amgen announcing it was slashing the list price of its breakthrough cholesterol-lowering drug Repatha by 60% in an effort to improve access and affordability for patients. Too many patients who had been prescribed the drug were walking away from the pharmacy empty handed because of sticker shock over … [Read more...] about A Closer Look At The Drug Rebate Proposal
Published in Forbes
Grace-Marie frequently contributes articles to Forbes.com as an expert in Healthcare Policy.
The Trump administration is trying in myriad ways to answer demands from consumers for lower prescription drug prices—a topic that got serious attention before the Senate Finance Committee on Tuesday where top executives of seven major drug companies testified. The president announced his “American Patients First” agenda in May, offering nearly 30 policy recommendations to … [Read more...] about Rebates And Drug Costs: What The New Proposal Would Mean
Puerto Rico’s economy was in distress before the island was slammed by hurricanes Irma and Marie, and it is struggling mightily now to recover. But new tax policies also are needed for this U.S. territory to have a fighting chance at long-term economic recovery. Damage to the island from the hurricanes was overwhelming, destroying homes and crippling businesses already suffering in the … [Read more...] about Puerto Rico’s Crisis Affects Us All